JavaScript is unavailable or disabled; so you are probably going to miss out on a few things. Everything should still work, but with a little less pzazz!
The William Harvey Research Institute - Barts and The London

Items

New study finds loss of Sacsin effects organisation of the cells cytoskeleton

ARSACS Foundation funded scientists at Queen Mary University of London, McGill University and Università Vita-Salute San Raffaele have just published a research paper in the journal Human Molecular Genetics, which looks at the cytoskeleton in cells cultured from ARSACS patients.

Date added: Tuesday, May 30, 2017


Some statin-related side-effects are due to 'nocebo' effect

Patients report more side effects when they know they are taking a statin, than when they do not know whether they are on the drug or a dummy pill, according to a study by researchers from Imperial College London and Queen Mary University of London (QMUL)

Date added: Wednesday, May 3, 2017


Research Matters - changing lives in east London and beyond

Date: Wednesday 24 May, 5pm - 7.30pmLocation: Perrin Lecture Theatre, Blizard Institute, 4 Newark Street, London E1 2AT  

Date added: Thursday, April 13, 2017


Success for WHRI at QMUL Engagement and Enterprise Awards 2017

On Tuesday 7th February 2017 QMUL hosted the second annual Engagement and Enterprise Awards to celebrate and showcase projects demonstrating excellence in the application and dissemination of research and teaching through public engagement, academic innovation, media relations and student enterprise.

Date added: Friday, March 3, 2017


William Harvey New Year Celebration 2017

On Friday the 3rd of February the WHRI held its annual New Year Celebration and featured 15 talks from the institute's postgraduates and young post-docs.

Date added: Tuesday, February 7, 2017


Genetic defect found to cause disease in multiple organs

New research from Queen Mary University of London (QMUL) has identified a novel syndrome in patients with kidney and adrenal disease.

Date added: Tuesday, February 7, 2017


William Harvey Research Institute hosts Church of England clergy visits

Church of England vicars visit the WHRI to experience clinical and genomic research at first hand, as part of a national initiative to help scientists and faith leaders engage in dialogue and enhance understanding of ethical issues in medicine.

Date added: Thursday, February 2, 2017


Professor Fulvio D'Acquisto receives large CPE award for a project titled 'CPD course to establish the Young Mind Science Knowledge Network'

East London school teachers to be provided CPD support and workshops to connect local schools with the Frontiers for Young Minds initiative, an open access scientific journal that publishes ground‐breaking science in language reviewed by teachers and their classes for accessibility.

Date added: Friday, January 27, 2017


Research summary: Enzymes responsible for tissue repair

Dr Jesmond Dalli explains how his new research has uncovered enzymes that are crucial for the repair and regeneration of tissues, and could lead to new treatments for diseases such as rheumatoid arthritis.  

Date added: Tuesday, October 11, 2016


WHRI researchers identify link between immunity and 'holidays'

A team of researchers at the WHRI are investigating ways in which holidays, music or a change of environment can bolster our immune systems in the fight against disease. 

Date added: Friday, September 30, 2016


Major global study reveals new hypertension and blood pressure genes

Thirty-one new gene regions linked with blood pressure have been identified in one of the largest genetic studies of blood pressure to date, involving over 347,000 people, and jointly led by Queen Mary University of London (QMUL) and the University of Cambridge. 

Date added: Tuesday, September 13, 2016


Genetic testing can pick out men at increased risk of testicular cancer

Testing for large numbers of genetic changes can identify men with over a 10-fold increased risk of testicular cancer, a new study shows. Researchers found that testing for newly identified genetic factors along with others found in their previous studies could pick out men at increased risk, who might potentially benefit from monitoring or preventative treatment.

Date added: Tuesday, June 13, 2017


QMUL study finds link between diesel pollution and heart damage

Diesel fumes have negative effects on the heart according to a new study by researchers at Queen Mary University of London (QMUL). 

Date added: Thursday, June 1, 2017


Statins help improve heart structure and function

Statins can improve the structure and function of the heart, according to a new study by researchers at Queen Mary University of London (QMUL)

Date added: Thursday, June 1, 2017


Data strongly suggests that the brain controls exercise capacity

A joint study by researchers from Queen Mary University of London (QMUL), University College London (UCL) and the University of Bristol suggests that the brain controls exercise capacity, a highly novel idea with ramifications for health in the general population as well as elite athletes.

Date added: Thursday, May 18, 2017


article News story: Winning photo reveals the latest in maternal health research
6, March , 2017

Dr Suchita Nadarki has been announced as one of the winners of the Wellcome Image Awards 2017. The winning photo, titled The Pacenta Rainbow, is based on her research into pregnancy complications, and will be shown at exhibitions held across the UK and internationally, including Russia and South Africa.

article News story: Obesity leads to harmful activation of the immune system
10, February , 2017

WHRI researchers find a link between a high-fat diet, obesity and cardiovascular disease risk.

article News story: New genes for height revealed in global study of 700,000 people
2, February , 2017

Over 80 new genetic variants that strongly influence human height have been discovered in a study led by Queen Mary University of London (QMUL), Montreal Heart Institute, The Broad Institute and the University of Exeter.

article News story: Over 100 new blood pressure genes could provide targets for treating hypertension
31, January , 2017

Study co-authored by Professor Mark Caulfield finds 107 new gene regions associated with high blood pressure, potentially enabling doctors to identify at-risk patients and target treatments.

article News story: Major Grant awarded to resolve debate on treatment after surgery
13, January , 2017

Queen Mary University of London (QMUL) awarded $1.5m (£1.2m) by Edwards Lifesciences to carry out a study into a debated therapy for preventing complications after major surgery.

article News story: How the brain helps the body fight bacteria
6, January , 2017

"The brain may not only control our thoughts and physical functions," writes Dr Jesmond Dalli in The Conversation.

article News story: White blood cell treatment could prevent leading cause of foetal death
12, December , 2017

Treating a type of white blood cell using hormones could improve the development of the placenta in women with pregnancy complications according to early research led by QMUL.

article News story: Maternal blood test may predict birth complications
24, October , 2016

A protein found in the blood of pregnant women could be used to develop tests to determine the health of their babies and aid decisions on early elective deliveries, according to an early study led by WHRI's Dr Marika Charalambous.

article News story: Parliamentarians pay visit to WHRI researchers
26, April , 2016

Chris Green MP, Stephen Timms MP and Baroness Neville-Jones were welcomed by researchers at Queen Mary University of London (QMUL) on a visit organised by the British Heart Foundation (BHF).

article News story: Amrita Ahluwalia awarded Women in Science and Engineering prize
16, November , 2015

Professor Amrita Ahluwalia from Queen Mary University of London (QMUL) has been awarded the 2015 Prize for Research by the WISE (Women in Science and Engineering) Campaign.

article News story: The results of the Research Excellence Framework (REF2014) bring excellent news for WHRI and our mother organisations
18, December , 2014

The results of the Research Excellence Framework (REF), published today, confirm Queen Mary University of London (QMUL)’s place in the very top group of research-led universities.

A new hope for reducing uncontrollable blood pressure

At The Royal London Hospital, on 30 June 2016, the Barts Blood Pressure Clinic became the first hospital in the country to provide two NHS patients with the innovative Barostim Neo™ device that could transform and save the lives of people living with uncontrollable blood pressure. 

Date added: Wednesday, July 12, 2017


The Fox Got You project visits WHRI for lab visit

Date added: Thursday, June 1, 2017


WHRI on now the UK pharmacology map

'UK Pharmacology on the Map' award was presented to the WHRI for its outstanding contribution to the discovery and development of medicines. 

Date added: Tuesday, December 15, 2015


Chemically modified insulin as a new marker to identify type 1 diabetes

A technique that could help predict, diagnose, stage and treat type 1 diabetes is currently being developed by researchers at the William Harvey Research Institute, Queen Mary University of London. 

Date added: Wednesday, November 15, 2017


CHIAROSCURO from War Crime Trials to Clinical Trials

Date: Tuesday 25 July 2017 at 7:30 pm Location: The Great Hall of St Bartholomew's Hospital, West Smithfield, London EC1 7BE

Date added: Thursday, July 20, 2017


Diabetes gene found that causes low and high blood sugar levels in the same family

A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.  

Date added: Tuesday, January 16, 2018


The first step in generating an artificial adrenal gland

In a new study, published in Cell Reports, researchers from Queen Mary University of London used cells derived from urine to take the first step in generating an artificial adrenal gland, which could help develop future treatments for adrenal gland disorders.

Date added: Wednesday, January 31, 2018


Multinational companies continue to produce unregulated antibiotics in India

Millions of unapproved antibiotics are being sold in India, according to a new joint study led by Dr Patricia McGettigan from the William Harvey Research Institute.

Date added: Tuesday, February 6, 2018


100,000 Genomes Project to sequence its 500th genome later this month

Professor Mark Caulfield spoke to Observer Science Editor Robin McKie about the pioneering work of the 100,000 Genomes Project as it approaches its halfway point.

Date added: Tuesday, February 6, 2018


£54 million award to transform health through data science

Queen Mary University of London has partnered with four other London universities - UCL, Imperial College London, King's College London and The London School of Hygiene & Tropical Medicine - in a new initiative to transform health through data science.

Date added: Wednesday, February 7, 2018


“Beetroot pill” could help save patients from kidney failure after heart x-ray

Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.

Date added: Thursday, February 22, 2018


Dr Suchita Nadkarni's 'The Placenta Rainbow' featured in National Geographic

Photo by William Harvey Research Institute (WHRI) and British Heart Foundation (BHF) Research Fellow shows differences in mouse placental development that can result from manipulation of the mother’s immune system.

Date added: Tuesday, February 27, 2018


Isolated white blood cell packages from patients with rheumatoid arthritis shown to be protective against inflammation

A new study by researchers from Queen Mary University of London finds that small packages released by white blood cells during inflammation can be used to prevent the activation of other white blood cells.  

Date added: Thursday, March 1, 2018


Aspirin helps treat tuberculous meningitis

The painkiller aspirin appears to reduce the risk of stroke and death in patients with the most deadly form of tuberculosis, according to a study by Queen Mary University of London, Oxford University Clinical Research Unit (Vietnam), Western General Hospital and University of Oxford.

Date added: Wednesday, March 7, 2018


New insights into why patients have a higher risk of heart attack in the morning

Cardiovascular disease patients have lower levels of an important family of protective molecules in their blood in the morning, which could be increasing their risk of blood clots and heart attacks at those times, according to early research led by Queen Mary University of London.

Date added: Thursday, March 8, 2018


Menopausal hormone therapy linked to having a healthier heart

Women who use menopausal hormone therapy appear to have a heart structure and function that is linked to a lower risk of heart failure, according to a study led by Queen Mary University of London.

Date added: Friday, March 9, 2018


Weak hand grip could be sign of a failing heart

Hand grip strength could be used as a simple measure of heart health, according to new research led by scientists at Queen Mary University of London.

Date added: Thursday, March 15, 2018


New project to transform treatment for children with arthritis

Researchers from Queen Mary University of London will join a UK-wide effort to drive the development of new treatments for children and young people with juvenile idiopathic arthritis (JIA) and its associated eye-inflammation condition, uveitis.

Date added: Wednesday, March 28, 2018


Hormone imbalance causes treatment-resistant hypertension

British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

Date added: Thursday, April 12, 2018


Pint of Science Festival, 14-16 May 2018

Pint of Science QMUL brings scientists out of the lab and in to your local pub.

Date added: Friday, April 13, 2018


Professor Gustav Born: 29th July 1921- 16 April 2018

A message sent on behalf of Professor Steve Thornton, Vice Principal (Health)

Date added: Wednesday, April 25, 2018


Professor Panos Deloukas elected as Fellow of The Academy of Medical Sciences

Professor of Cardiovascular Genomics at Queen Mary University of London has been recognised for his outstanding contribution to genomic medicine. 

Date added: Thursday, May 10, 2018


Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science

Queen Mary University of London has appointed four postdoctoral research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Innovation’s Rutherford Fund. One of the fellows include WHRI's Dr Adriano Barbosa.

Date added: Monday, May 14, 2018


QMUL and UCL joint study identifies genes linked to impaired capacity to modulate heart rate during and after exercise

A new study by researchers at Queen Mary University of London (QMUL) and University College London (UCL) has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.

Date added: Thursday, May 17, 2018


Lunch & Learn: Cutting Edge Studies in Autoimmune Disease

Date: 1 June 2018Time: 12:00pmVenue: William Harvey Research Institute, Charterhouse Square Campus

Date added: Friday, May 18, 2018


Surgery involving ultrasound energy found to treat high blood pressure

An operation that targets the nerves connected to the kidney has been found to significantly reduce blood pressure in patients with hypertension, according to the results of a clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust, and supported by the National Institute for Health Research (NIHR).

Date added: Wednesday, May 23, 2018


New lab technology could reveal treatments for muscle-wasting disease

Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.

Date added: Wednesday, June 6, 2018


Q&A with Dr Li Chan

Research paper: MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation

Date added: Thursday, June 7, 2018


ESE’s Scientific Programme Chair discusses Brexit effects on European Reference Network in the UK Parliament

Professor Márta Korbonits, Professor of Endocrinology at Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Scientific Programme Chair of the European Society of Endocrinology, and representative of BioMed Alliance, will be discussing the effects of Brexit on the European Reference Networks (ERNs), in Westminster, Monday 9 July.

Date added: Friday, July 6, 2018


Graduation joy for WHRI Pharmacology students

Date added: Monday, July 30, 2018


New research links low levels of air pollution with serious changes in the heart

Researchers from Queen Mary University of London have found that people exposed to air pollution levels well within UK guidelines have changes in the structure of the heart, similar to those seen in the early stages of heart failure.

Date added: Friday, August 3, 2018


Blood pressure medications and statins found to provide long-term cardiovascular benefits

Death rates from heart disease and stroke could be significantly lowered by prescribing statins alongside blood pressure-lowering drugs, according to the results from a clinical trial led by Queen Mary University of London and Imperial College London.

Date added: Tuesday, August 28, 2018


Study of one million people leads to world’s biggest advance in blood pressure genetics

Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date, led by Queen Mary University of London and Imperial College London.

Date added: Monday, September 17, 2018


Researchers awarded for lifetime achievements in blood pressure research

Two academics from Queen Mary University of London have received prestigious awards from the International Society of Hypertension (ISH) in recognition of their achievements in blood pressure research.

Date added: Monday, September 24, 2018


Landmark TB research announced at the UN General Assembly

A landmark international research project, involving researchers from Queen Mary University of London, has shown that we can now use our knowledge of the tuberculosis (TB) genetic code to predict which drugs are best for treating a patient’s infection.

Date added: Thursday, September 27, 2018


Genetic tool to predict adult heart attack risk in childhood

People at high risk of a heart attack in adulthood could be identified much earlier in life with a one-off DNA test, according to new research published in the Journal of the American College of Cardiology.

Date added: Wednesday, October 10, 2018


Professor Márta Korbonits delivers inaugural Lady Estelle Wolfson lecture at the RCP

Professor Márta Korbonits gave the Lady Estelle Wolfson lecture in translational medicine at the Royal College of Physicians on the 24th October 2018 during the Acute and General Medicine Conference.

Date added: Monday, October 29, 2018


Research in Focus

Dr Gloria Lliso-Ribera, Rheumatology Clinical Research Fellow

Date added: Thursday, November 22, 2018


Professor Chris Thiemermann honoured for his contributions to science

In October 2018, Chris Thiemermann, Professor of Pharmacology and Centre Lead for Translational Medicine & Therapeutics at the William Harvey Research Institute, received the prestigious Albert Nelson Marquis Lifetime Achievement Award.

Date added: Thursday, November 8, 2018


WHRI researchers in top 1 per cent worldwide

Three researchers from the William Research Institute have been placed in the top 1 per cent in the world, in this year’s Highly Cited Researchers list.

Date added: Tuesday, November 27, 2018


Genomics project reaches goal of 100,000 genomes sequenced from NHS patients

UK Health Secretary Matt Hancock has today announced that a project involving Queen Mary University of London researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients.

Date added: Thursday, December 6, 2018


Researcher named as one of the most inspirational women in science

Professor Federica Marelli-Berg from Queen Mary University of London has been named by the British Heart Foundation (BHF) as one of the top 10 inspirational women in science.

Date added: Friday, February 15, 2019


Professor of Endocrine Medicine achieves recognition for Excellence in Education

The winners of Queen Mary’s new scheme of annual Education Excellence Awards and President and Principal’s Prizes were announced at a ceremony on 20 February 2019

Date added: Friday, February 22, 2019


Working long hours linked to depression in women

Women who work more than 55 hours a week are at a higher risk of depression compared to men, according to a UCL-led study with Queen Mary University of London.

Date added: Tuesday, February 26, 2019


BHF invests £34m in top universities, helping to safeguard UK’s world-class research status

The British Heart Foundation (BHF) has this week announced £34million of new funding across 12 universities, in a move that strengthens world-class, UK-led heart and circulatory disease research.

Date added: Wednesday, March 6, 2019


QMUL researchers win prestigious award for Vascular Biology publication

A publication by researchers from the Centre for Microvascular Research at the William Harvey Research Institute has received the highly prestigious Servier Award in Microcirculation.

Date added: Thursday, March 7, 2019


QMUL researchers seek treatment for arthritis as part of new EU-funded project

Researchers from Queen Mary University of London are about to start work on a new EU-funded project to discover novel therapeutic targets for osteoarthritis and rheumatoid arthritis.

Date added: Thursday, March 14, 2019


Poor lung function in shorter people linked to increased risk of heart disease

Results from a study led by researchers from Queen Mary University of London has found that an association between shorter stature and higher risk of heart disease is mainly attributed to our lungs.

Date added: Thursday, March 28, 2019


Quality Improvement in emergency surgery shows no difference in patient survival

Researchers from Queen Mary University of London studied the effectiveness of one of the largest ever national quality improvement programmes in the National Health Service (NHS) and found no improvement in patient survival.

Date added: Thursday, April 25, 2019


London heart disease patients take part in clinical trial to test alternative to statins

A clinical trial, coordinated by researchers from Queen Mary University of London, is currently recruiting patients in London to see whether a new cholesterol-lowering drug could save lives in people who are intolerant to statins.

Date added: Monday, May 20, 2019


DNA discovery could have implications for mitochondrial donation treatment

Mitochondria, the ‘batteries’ that produce our energy, interact with the cell’s nucleus in subtle ways previously unseen in humans, according to research involving academics from Queen Mary University of London.

Date added: Friday, May 24, 2019


Follow us on LinkedIn

We are pleased to announce that we are now officially on LinkedIn!

Date added: Thursday, May 30, 2019


Coffee not as bad for heart and circulatory system as previously thought

Drinking coffee might keep us up at night, but new research has given us a reason to sleep easy knowing that the popular drink isn’t as bad for our arteries as some previous studies would suggest. The research from Queen Mary University of London has shown that drinking coffee, including in people who drink up to 25 cups a day, is not associated with having stiffer arteries.

Date added: Monday, June 3, 2019


Leading genomics expert awarded knighthood in the Queen’s birthday honours

Professor Mark Caulfield, the interim Chief Executive at Genomics England and Professor of Clinical Pharmacology at Queen Mary University of London, has been awarded a knighthood in the Queen’s Birthday Honours List.  

Date added: Friday, June 7, 2019


Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Non-Cardiovascular Diseases

A new study led by researchers at Queen Mary University has shown how genetic predisposition to coronary heart disease (including heart attacks) is genetically correlated to other diseases.

Date added: Tuesday, June 11, 2019


EMR delivers “Creating without constraint: Arthritis and art” at QMUL’s Tate Exchange

The Centre for Experimental Medicine and Rheumatology (EMR) at the William Harvey Research Institute is committed to engaging with the public and has participated in the Barts and Queen Mary Science Festival for a number of years, offering children the opportunity to try gloves that simulate the effect of arthritis and to ‘see’ inside their joints using ultrasound, so when QMUL Arts and Culture asked for proposals for the 2019 Tate Exchange EMR decided to build on this and submit a project.  

Date added: Monday, June 24, 2019


Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals

A new joint study involving researchers at Queen Mary University of London has identified background subclinical changes on the electrocardiogram as risk factors in cardiovascular mortality.

Date added: Tuesday, June 25, 2019


2019 WHRI Annual Review Summary

The William Harvey Annual Review took place on the 12th of June 2019 at the Derek Willoughby Lecture Theatre, Charterhouse Square.

Date added: Thursday, June 27, 2019


WHRI Academic voted 2019 Teacher of the Year by MBBS students

We are pleased to announce that Dr Fu Liang Ng, Clinical Senior Lecturer in Clinical Pharmacology at the William Harvey Research Institute, was voted Teacher of the Year by the MBBS students for 2019.

Date added: Wednesday, July 17, 2019


Health tech start-up partners with the William Harvey Research Institute to develop personalised treatment for high blood pressure

Closed Loop Medicine (CLM), the Cambridge based therapeutics company that helps doctors and healthcare providers to deliver personalised treatment regimens, has raised £1.3 million in research grant funding from the InnovateUK Innovation Accelerator, Longwall Ventures and IQ Capital. The InnovateUK Innovation Accelerator is a new scheme that enables InnovateUK to match fund a select group of company investors.

Date added: Thursday, July 25, 2019


Outstanding impact in teaching recognised in national award

Professor Maralyn Druce from Queen Mary University of London has been announced as a new National Teaching Fellow by Advance HE today.

Date added: Monday, August 5, 2019


Researchers from the Centre for Endocrinology win 2019 EJE Readers’ Choice Award for joint study into rare disease

Q&A with , Reader and Honorary Consultant in Paediatric Endocrinology

Date added: Wednesday, August 7, 2019


Success for WHRI at the International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases

Scientists from 21 countries travelled to St. Petersburg, Florida, USA last week to attend the 16th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, which is sponsored by the Eicosanoid Research Foundation.

Date added: Tuesday, November 5, 2019


WHRI Emeritus Professor awarded Faculty of Intensive Care Gold Medal

Professor Charles Hinds recognised for his exceptional contribution to intensive care medicine.  

Date added: Friday, November 8, 2019


Researchers find potential new target for treatment of inflammatory disease

A new joint study involving researchers from Queen Mary University of London has identified potential new targets to tackle lactate-induced chronic inflammation. 

Date added: Friday, November 8, 2019


Cardiovascular Genomics Professor among most highly cited researchers

The William Harvey Research Institute is proud to announce that Panos Deloukas, Professor of Cardiovascular Genomics, has been named in the top 0.1% of the world’s most influential researchers.

Date added: Tuesday, November 26, 2019


Researchers look behind the biological curtain on how fish oil might fight inflammatory disease

The debate about the potential for exploiting omega-3 fatty acids to improve health has raged for years.

Date added: Friday, December 13, 2019


Success for the WHRI at the Queen Mary Education Excellence Awards and President and Principal’s prize

We are pleased to announce that Dr Parjam Zolfaghari, Professor Nick Goulding and Dr Martin Carrier from Queen Mary’s William Harvey Research Institute (WHRI) were one of several winners at the Queen Mary Education Excellence Award and President and Principal's Prizes for 2019/20.

Date added: Friday, December 13, 2019


Researchers identify possible link between cannabis use and structural changes to heart

Regular cannabis use could affect the structure and function of the heart, research led by a team at Queen Mary University of London suggests.

Date added: Thursday, December 19, 2019


Pinpointing rare disease mutations

A new study from Queen Mary University of London and EMBL’s European Bioinformatics Institute has uncovered the genes essential for supporting life, which could help researchers to identify mutations responsible for rare childhood diseases.

Date added: Friday, January 31, 2020


Queen Mary Professor in Endocrinology elected to the Hungarian Academy of Medical Sciences

Professor Márta Korbonits from the William Harvey Research Institute at Queen Mary University of London was recently elected to the Hungarian Academy of Medical Sciences.

Date added: Wednesday, February 5, 2020


New research identifies a distinct way to control joint inflammation and arthritis

In a new study, published in the journal Nature Communications, researchers from Barts and The London School of Medicine and Dentistry at Queen Mary University of London observe that the promotion of synovial fibroblast senescence activates tissue protective mechanisms in the arthritic joint.

Date added: Thursday, February 6, 2020


International team delivers research breakthrough for leading cause of blindness

Researchers have identified a new protein linked to age-related macular degeneration (AMD) that could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone.

Date added: Friday, February 7, 2020


World first in AI helps predict heart attacks and stroke

Artificial intelligence has been used for the first time to instantly and accurately measure blood flow, in a new study involving researchers from Queen Mary University of London.  

Date added: Friday, February 14, 2020


Diabetes drug reduces complications of long-term steroid therapy

A drug used to treat type 2 diabetes could offer a simple and cheap solution to reduce dangerous side effects of steroid treatment, new research from Queen Mary University of London suggests.

Date added: Wednesday, February 26, 2020


Queen Mary professor to lead new NHS Nightingale Hospital

Charles Knight, Professor of Cardiology at Queen Mary University of London and Consultant Cardiologist at Barts Health NHS Trust, has been announced as the Chief Executive of the new NHS Nightingale Hospital London.

Date added: Wednesday, April 8, 2020


Queen Mary and Barts Health launch Covid-19 research programme

Queen Mary University of London and Barts Health NHS Trust, as part of their Barts Life Sciences initiative, have begun a new programme of Covid-19 research across Barts Health hospitals, including NHS Nightingale Hospital London.

Date added: Monday, April 20, 2020


Antibodies could provide new treatment for OCD

Mental health conditions such as obsessive compulsive disorder could be treated in a new way using drugs that target the immune system, research suggests.

Date added: Tuesday, April 21, 2020


Inside the lab testing thousands of NHS samples for COVID-19

Queen Mary University of London has been providing support to the UK Lighthouse Labs Network – the national COVID-19 diagnostic lab network. As well as donating a number of laboratory machines, a team of research staff have been seconded to help test thousands of samples from NHS workers every day. Dr Neil Dufton, Lecturer in Inflammatory Sciences at Queen Mary’s William Harvey Research Institute, has been volunteering at one of the Lighthouse Labs in Milton Keynes and shares his experiences in this blog post.

Date added: Tuesday, April 28, 2020


Researchers use magnetism to keep drugs at disease sites

New research from Queen Mary University of London suggests that a novel magnetism-based drug delivery approach could help ensure drugs are not removed from where they are needed in the body.

Date added: Thursday, April 30, 2020


The uncertainties in modelling the COVID-19 pandemic

Dr Deepti Gurdasani from Queen Mary’s William Harvey Research Institute and Hisham Ziauddeen from University of Cambridge are co-authors of a correspondence piece in The Lancet Global Health which suggests there were limitations in some assumptions used in the COVID-19 pandemic models forming part of the scientific evidence considered by the UK Government. In this blog post, they explain the importance of real-world evidence being used alongside modelling to develop public health responses.

Date added: Friday, May 1, 2020


Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through Missplicing

A joint international study led by researchers at QMUL explores how variants that might be overlooked in standard analyses can be pathogenic when combined with much rarer disruptive changes.

Date added: Friday, May 1, 2020


Discovery of New Genes Modulating the Tpe Interval: an Electrocardiographic risk marker for Sudden Cardiac Death

Thirty-eight new gene regions that influence the Tpe interval, an electrocardiographic marker associated with susceptibility to malignant ventricular arrhythmias and sudden cardiac death, have been discovered in the largest genetic study to date. 

Date added: Thursday, May 7, 2020


Scientists discover more than 200 genetic factors causing heart arrhythmias

Hundreds of new links have been found between people’s DNA and the heart’s electrical activity, according to a study of almost 300,000 people led by researchers at Queen Mary University of London and the Broad Institute of MIT and Harvard.

Date added: Thursday, May 21, 2020